Israel - English - Ministry of Health

padagis israel agencies ltd, israel - glyceryl trinitrate - ointment - glyceryl trinitrate 0.4 % - glyceryl trinitrate - glyceryl trinitrate - for relief of pain associated with chronic anal fissure. in the clinical development of the drug a modest effect has shown on improvement in average daily pain intensity.

Israel - English - Ministry of Health

abbott medical laboratories ltd, israel - clarithromycin - tablets slow release - clarithromycin 500 mg - clarithromycin - clarithromycin - for treatment of infections caused by susceptible organisms. for lower respiratory tract infections, upper respiratory tract infections, skin and soft tissue infections

Israel - English - Ministry of Health

abbott medical laboratories ltd, israel - clarithromycin - granules for reconstitution - clarithromycin 125 mg / 5 ml - clarithromycin - clarithromycin - bronchitis, pharyngitis, tonsilitis pneumonia skin infections due to susceptible microorganisms. treatment of mycobacterium avium complex in patients with aids. treatment of otitis media.

Israel - English - Ministry of Health

trima israel pharmaceutical products maabarot ltd - voriconazole - tablets - voriconazole 200 mg - voriconazole - treatment of: invasive aspergillosis, candidemia in non-neutropenic patients, fluconazole-resistant serious invasive candida infections (including c. krusei), serious fungal infections caused by scedosporium spp. and fusarium spp. voriconazole should be administered primarily to immunocompromised patients with progressive, possibly life-threatening infections. prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct) recipients.

Israel - English - Ministry of Health

unipharm ltd, israel - clarithromycin - coated tablets - clarithromycin 250 mg - clarithromycin - clarithromycin - karin is indicated in the treatment of infections caused by one or more susceptible organisms. lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. upper respiratory tract infections for example, sinusitis and pharyngitis. karin is also indicated in skin and soft tissue infections of mild to moderate severity. karin is also indicated in combination with proton pump inhibitor for the eradication of h.pylori in patients with proven duodenal ulcers.

Israel - English - Ministry of Health

unipharm ltd, israel - clarithromycin - coated tablets - clarithromycin 500 mg - clarithromycin - clarithromycin - karin is indicated in the treatment of infections caused by one or more susceptible organisms. lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. upper respiratory tract infections for example, sinusitis and pharyngitis. karin is also indicated in skin and soft tissue infections of mild to moderate severity.karin is also indicated in combination with proton pump inhibitor for the eradication of h.pylori in patients with proven duodenal ulcers. treatment of mycobacterium avium complex infection in aids patients

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - erythromycin as stearate - tablets - erythromycin as stearate 500 mg - erythromycin - erythromycin - treatment of the following infections when caused by susceptible organisms: upper and lower respiratory tract infections. skin and soft tissue infections. conjunctivitis of the newborn caused by chlamydia trachomatis. urogenital infections caused by chlamydia trachomatis. venereal diseases (as an alternative regimen to penicillins and tetracyclines). intestinal amebiasis. legionnaires' disease. long-term prophylaxis in rheumatic fever. short-term prophylaxis against bacterial endocarditis in patients hypersensitive to penicillin who have congenital heart disease or rheumatic or other acquired valvular heart disease when undergoing dental procedures and surgical procedures of the upper respiratory tract. enteric infections caused by campylobacter jejuni.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - erythromycin as stearate - tablets - erythromycin as stearate 250 mg - erythromycin - erythromycin - treatment of the following infections when caused by susceptible organisms: upper and lower respiratory tract infections. skin and soft tissue infections. conjunctivitis of the newborn caused by chlamydia trachomatis. urogenital infections caused by chlamydia trachomatis. venereal diseases (as an alternative regimen to penicillins and tetracyclines). intestinal amebiasis. legionnaires' disease. long-term prophylaxis in rheumatic fever. short-term prophlaxis against bacterial endocarditis in patients hypersensitive to penicillin who have congenital heart disease or rheumatic or other acquired valvular heart disease when undergoing dental procedures and surgical procedures of the upper respiratory tract. enteric infections caused by campylobacter jejuni.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - erythromycin as stearate - tablets - erythromycin as stearate 500 mg - erythromycin - treatment of the following infections when caused by susceptible organisms: upper and lower respiratory tract infections. skin and soft tissue infections. conjunctivitis of the newborn caused by chlamydia trachomatis. urogenital infections caused by chlamydia trachomatis. venereal diseases (as an alternative regimen to penicillins and tetracyclines). intestinal amebiasis. legionnaires' disease. long-term prophylaxis in rheumatic fever. short-term prophylaxis against bacterial endocarditis in patients hypersensitive to penicillin who have congenital heart disease or rheumatic or other acquired valvular heart disease when undergoing dental procedures and surgical procedures of the upper respiratory tract. enteric infections caused by campylobacter jejuni.

Israel - English - Ministry of Health

novartis israel ltd - nilotinib as monohydrate - capsules - nilotinib as monohydrate 200 mg - nilotinib - nilotinib - treatment of philadelphia chromosome positive chronic myeloid leukaemia (ph+ cml) in chronic or accelerated phase in patients resistant to or experiencing significant toxicity during treatment with imatinib.treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.